S&P 500 Industrials Sector SEC Filings — April 15, 2026

15-04-2026

Basin Electric Power Cooperative filed an S-4 registration statement on April 15, 2026, for an exchange offer to exchange up to $700,000,000 aggregate principal amount of its outstanding 5.850% First Mortgage Obligations, 2025 Series A Bonds due 2055 (Original Bonds, CUSIP Nos. 070101 AJ9 and U06865 AB2) for a like principal amount of registered Exchange Bonds (CUSIP No. 070101 AK6). The Exchange Bonds have substantially identical terms to the Original Bonds except for the removal of transfer restrictions, registration rights, and additional interest provisions. The offer expires at 5:00 p.m., New York City time, on a date in 2026 (to be specified), unless extended, and will not increase the company's outstanding indebtedness as exchanged Original Bonds will be retired.

• ·Exchange Bonds secured equally and ratably under Amended and Restated Indenture dated May 5, 2015, by mortgage lien on substantially all owned tangible and certain intangible properties.
• ·No public market currently exists for Original Bonds; no plans to list Exchange Bonds.
• ·Broker-dealers receiving Exchange Bonds must deliver prospectus for resales for up to 180 days post-expiration.

15-04-2026

Bank of Hawaii Corporation issued supplemental proxy materials urging shareholders to vote FOR Proposal 2, the non-binding Say-on-Pay approval for 2025 named executive officer compensation, citing strong 2025 financial results including diluted EPS of $4.63, net income of $206 million, assets of $24.2 billion, deposits of $21.2 billion and loans of $14.1 billion (both up YoY), record Q4 operating revenue, top quartile ROCE and non-performing assets vs. peers, and PPNR exceeding goals. However, ISS and Glass Lewis recommended against due to perceived misalignment of pay with 5-year TSR relative to peers, though the company notes recent TSR outperformance post-January 2026 earnings, a 2024 compensation program overhaul with shareholder support (94-95% in prior votes), and unique Hawaii talent retention challenges. The filing defends pay levels amid CEO succession without further reductions.

• ·Diluted EPS of $4.63 for full year 2025.
• ·Consistent quarterly growth in net interest income and margin throughout 2025.
• ·Record high operating revenue in Q4 2025.
• ·LTI weighted 70% ROCE and 30% TSR over three-year period under new program.
• ·STI balanced scorecard: profitability, asset quality, financial returns, strategic measure, individual performance.
• ·Annual Meeting scheduled for April 24, 2026.

15-04-2026

U.S. Physical Therapy, Inc. entered into a Fourth Amended and Restated Credit Agreement on April 14, 2026, amending and restating the Third Amended and Restated Credit Agreement dated June 17, 2022, to provide a modified revolving credit facility and term loan facility. Bank of America, N.A. serves as Administrative Agent, Swingline Lender, and L/C Issuer, with other banks including Regions Capital Markets as Syndication Agent and Citizens Bank, N.A., JPMorgan Chase Bank, N.A., and U.S. Bank National Association as Co-Documentation Agents. The agreement constitutes an extension and renewal of prior indebtedness without extinguishment.

• ·CUSIP Numbers: Published 90355KAD9, Revolver 90355KAE7, Term Loan 90355KAF4.
• ·Applicable Rate grid has 5 pricing levels based on Consolidated Leverage Ratio from <1.25:1.0 (Level 1: Term SOFR/LC Fee 1.250%, Base Rate 0.250%, Commitment Fee 0.225%) to ≥3.25:1.0 (Level 5: 2.250%, 1.250%, 0.350%).
• ·SEC 8-K filed April 15, 2026, Items 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 9.01 (Financial Statements and Exhibits).

15-04-2026

This DEF 14A proxy statement details the Audit Committee's review and recommendation of the 2025 audited financial statements for inclusion in the Form 10-K, the Nominating and Corporate Governance Committee's activities including 3 meetings in 2025 and recommendation of director nominees H. Michael Schwartz, Stephen G. Muzzy, and Alexander S. Vellandi, and the Compensation Committee's 2 meetings in 2025 with no direct executive officer compensation. All committees were formed on February 26, 2021, with independent directors Muzzy and Vellandi serving in leadership roles. No financial performance metrics or changes are discussed.

• ·Audit Committee discussed financial reporting quality, auditor independence, and audit scope for year ended December 31, 2025.
• ·Nominating Committee considers diverse backgrounds, real estate expertise, and independence in director nominations.
• ·Compensation Committee oversees director compensation and equity awards to Advisor affiliates; no charter currently.
• ·Conflicts of interest approvals include advisor agreements, property management, loans, and affiliate transactions.

15-04-2026

Pasqal Holding SAS CEO Wasiq Bokhari presented at the 'Pasqal Thoughts 2026: Defining Quantum Now' event, highlighting achievements including experimentally verified quantum simulations of real-world materials (unachievable classically) and solving differential equations using neutral atom logical qubits. The company announced plans to go public via a business combination with Bleichroeder Acquisition Corp. II, targeting a Nasdaq listing in H2 2026, supported by €340M ($400M) in new funding comprising €170M ($200M) private financing and €170M ($200M) committed convertible financing. Pasqal emphasized deployments of quantum processors in standard data centers and HPC environments, with no reported setbacks.

• ·Pasqal quantum processors deployed in high-performance computing (HPC) data centers and accessible via cloud.
• ·In-house manufacturing capabilities for QPUs operational in standard data centers without cryogenics.
• ·Nasdaq listing planned for H2 2026, followed by potential Euronext Paris listing.
• ·Quantum Advantage demonstrations in materials science targeted by end of Q1 2026.
• ·Part of IBM Quantum Network with integration for hybrid HPC/cloud environments.

15-04-2026

Otter Tail Corporation held its Annual Shareholder Meeting on April 13, 2026, where shareholders re-elected directors Jeanne H. Crain, John D. Erickson, and Nathan I. Partain to three-year terms; approved in a non-binding advisory vote the compensation of Named Executive Officers; ratified Deloitte & Touche LLP as independent auditors for 2025; and approved the amendment and restatement of Bylaws to include an exclusive forum provision. All four proposals passed with strong majority support, including over 27 million 'for' votes for each director out of 34,713,440 shares voted and nearly unanimous auditor ratification at 34,240,352 'for'. A total of 41,953,525 shares were entitled to vote as of the February 12, 2026 record date.

• ·Director Jeanne H. Crain: 28,073,952 votes for, 325,613 withheld
• ·Director John D. Erickson: 28,002,930 votes for, 396,635 withheld
• ·Director Nathan I. Partain: 27,351,500 votes for, 1,048,065 withheld
• ·Executive compensation advisory: 27,362,072 for, 672,105 against, 365,388 abstained
• ·Auditor ratification: 34,240,352 for, 404,111 against, 68,977 abstained
• ·Bylaws amendment: 24,816,084 for, 3,378,544 against, 204,937 abstained

15-04-2026

15-04-2026

15-04-2026

15-04-2026

DexCom, Inc. (DXCM) filed Definitive Additional Materials (DEFA14A) on April 15, 2026, as a proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is not preliminary or confidential. No financial metrics, performance data, or substantive proposals are detailed in the provided header.

• ·Filing Type: DEFA14A (Schedule 14A)
• ·Filed by the Registrant

15-04-2026

M&T Bank Corporation reported Q1 2026 net income of $664 million ($4.13 diluted EPS), up 14% YoY from $584 million ($3.32 EPS) but down 13% QoQ from $759 million ($4.67 EPS), with net interest income at $1,752 million, down 2% QoQ but up 3% YoY alongside NIM expansion to 3.71%. Average loans grew 1% QoQ and 3% YoY to $138,423 million, driven by commercial and industrial loans, though partially offset by declines in commercial real estate (-3% QoQ, -11% YoY) and consumer loans. Noninterest expense rose 4% QoQ to $1,438 million, pushing the efficiency ratio to 58.3% from 55.1%, while the company repurchased 5.5 million shares for $1.25 billion.

• ·Nonaccrual loans declined 1% QoQ to $1,240 million and 19% YoY.
• ·Provision for credit losses increased 12% QoQ to $140 million.
• ·Average interest-bearing deposits at banks fell 10% QoQ and 18% YoY to $16,231 million.
• ·Short-term borrowings rose 176% QoQ to $5,695 million.

15-04-2026

FG Merger II Corp. (FGMC) filed Amendment No. 3 to its Form S-4 registration statement on April 14, 2026, advancing its business combination with BOXABL Inc. via a Nevada-to-Texas conversion and two-step merger process under a Merger Agreement dated August 5, 2025 (as amended). The deal provides for aggregate merger consideration based on $3,500,000,000 at $10 per share, with BOXABL common stock converting via the Common Exchange Ratio and preferred stock via the Preferred Exchange Ratio; FGMC will rename to BOXABL Inc. post-closing. The prospectus covers 247,331,061 shares of common stock and 102,668,939 shares of preferred stock, among others, with no operational financial metrics or period comparisons disclosed.

• ·Merger Agreement dated August 5, 2025, amended November 3, 2025 and April 6, 2026.
• ·Special meetings of FGMC and BOXABL stockholders to approve the Business Combination.
• ·No fractional shares issued; rounded up with pro rata reduction to Paolo Tiramani and Galiano Tiramani affiliates.
• ·FGMC classified as smaller reporting company and emerging growth company.

15-04-2026

Exchange Traded Concepts, LLC filed its 13F-HR combination report on April 15, 2026, disclosing institutional equity holdings as of March 31, 2026, across multiple managers including Saba Capital Management, L.P. and Miller Value Partners, LLC. Key positions include Amazon.com Inc. at $188745937, Alphabet Inc. CAP STK CL A at $137218168, and Alphabet Inc. CAP STK CL C at $38387031, with no prior period data provided for comparisons. The portfolio spans over 100 securities with no reported changes or performance metrics.

• ·Filing includes holdings in over 100 securities such as AAR CORP (value 21345), ADMA BIOLOGICS INC (31508), and Abbott Laboratories (754316 OTR 1, 4220045 OTR 14)
• ·Report period end date: March 31, 2026
• ·Certified by N Dennis Lowenfels on April 14, 2026

15-04-2026

Avondale Wealth Management filed its 13F-HR on April 15, 2026, disclosing 71 equity holdings as of March 31, 2026, with a total market value of $203460351. The portfolio is heavily weighted toward ETFs, with the largest position in iShares Core S&P 500 ETF at $37212213, followed by iShares Core S&P Mid-Cap ETF at $20055794 and Invesco QQQ Trust at $19064689. Other notable holdings include American Century U.S. Small Cap Value ETF ($17370796) and Dimensional Emerging Markets Core Equity Management ETF ($14149508).

• ·Filing covers period ending March 31, 2026
• ·All holdings reported as sole discretionary
• ·Portfolio includes significant allocations to Bitcoin ETFs (e.g., ARK 21Shares Bitcoin ETF $204078, iShares Bitcoin Trust $537880) and energy/oil funds

15-04-2026

RetinalGenix Technologies Inc. (RTGN) filed its 10-K annual report on April 15, 2026, detailing extensive risk factors across financial, operational, regulatory, and market domains. The company highlights no revenue from commercial sales, ongoing net losses, substantial doubt about its ability to continue as a going concern, dependency on future capital raises that may dilute shareholders, and uncertainties in product development, regulatory approval, manufacturing, and commercialization. Additional risks include product liability, competition, IT dependencies, key personnel retention, stock volatility, and anti-takeover provisions.

15-04-2026

Brookfield Asset Management Ltd. (BAM) announced on April 14, 2026, an offering of US$550 million principal amount of 4.832% senior notes due 2031 and US$450 million re-opening of its existing 5.298% senior notes due 2036. The re-opening will increase the aggregate principal amount of the 2036 notes series from the previously issued US$400 million (on November 18, 2025) to US$850 million. Preliminary and final Canadian term sheets for the notes are filed as Exhibits 99.1 and 99.2.

• ·Filing submitted on April 15, 2026, pursuant to Items 8.01 and 9.01 of Form 8-K.
• ·Notes offerings incorporate term sheets into BAM’s Registration Statement on Form F-10 (File No. 333-293350).

15-04-2026

M2i Global, Inc. (MTWO), a Nevada-based emerging growth company and smaller reporting company, filed a 10-KT transition report for the short fiscal period from December 1, 2025, to December 31, 2025, covering business operations in critical minerals and materials essential for U.S. national defense and economic security. The company aims to develop a diversified portfolio of projects to address U.S. supply chain vulnerabilities amid foreign export bans on minerals like antimony, tungsten, and tantalum. As of March 31, 2026, 760,182,298 common shares were outstanding, with an aggregate market value of non-affiliate common equity at $64,912,936.

• ·Registrant is a non-accelerated filer, smaller reporting company, and emerging growth company.
• ·No securities registered pursuant to Section 12(b) or 12(g) of the Exchange Act.
• ·Principal executive offices at 885 Tahoe Blvd., Incline Village, NV 89451.
• ·I.R.S. Employer Identification No.: 37-1904036.

15-04-2026

Tradewinds Universal reported revenue of $133,222 for the year ended December 31, 2025, down 22% YoY from $171,596 in 2024, while gross profit declined 11% to $133,222 due to zero COGS in 2025 versus $21,645 previously. Operating expenses surged 368% to $1,026,099, driven by $886,105 in consulting and $60,695 in marketing, resulting in a net loss widening to $892,877 from $115,743. However, the company raised equity through share issuances totaling approximately $1.17M (including $894,700 for services and $200,000 for assets), boosting total assets to $307,333 from $31,510 and cash to $16,638 from $210.

• ·New auditor Fruci & Associates II, PLLC (PCAOB #05525) served since 2025.
• ·Intangible assets increased to $216,500 (net) from $31,300, including AI App at $190,000.
• ·No debt or accounts payable; zero current liabilities both years.
• ·Net cash used in operating activities increased to $57,572 from $28,003.
• ·On June 8, 2025, issued 1,500,000 shares for services to a non-affiliated entity.

15-04-2026

CTT Pharmaceutical Holdings, Inc. (CTTH), a developer of fast-dissolving oral drug delivery strips for pharmaceuticals, nutraceuticals, and nicotine, filed an S-1/A amendment on April 15, 2026, registering 6,250,000 shares of common stock for resale by RH2 Equity Partners under an Equity Line of Credit Agreement dated September 8, 2025, potentially providing up to $10 million in proceeds to the company. Current common stock outstanding is 58,712,232 shares, increasing to 64,962,232 post-offering, with shares trading on OTCQB at $0.065 as of April 8, 2026. No financial performance metrics or period-over-period comparisons are provided in the filing.

• ·Filing effective as soon as practicable after SEC declaration.
• ·Common stock listed on OTCQB under symbol CTTH.
• ·Principal executive offices: 1646 W Snow Avenue Suite 138, Tampa, FL 33606.
• ·Company classified as non-accelerated filer, smaller reporting company, and emerging growth company.

15-04-2026

Edenor's 2025 tariff category analysis shows Residential users (46% of electricity sales) declined 1.6% YoY in energy sales value (GWh), while Industrial users (15%) decreased 2.7% YoY; Small Commercial (8%) grew a flat 0.1% and Medium Commercial (7%) a flat 0.8%. The filing highlights risks including potential inability to collect government-financed energy sales, cybersecurity threats, and capital movement restrictions affecting ADS holders. Operational updates include hardware renewals for the SCADA system and printer/plotter inventory.

• ·Risk of inability to collect energy sales for neighborhoods financed by Argentine Government, Province of Buenos Aires, and Autonomous City of Buenos Aires.
• ·Cybersecurity risks from IT interruptions or cyber-attacks could impact business, financial condition, operations, and cash flows.
• ·Capital outflow restrictions from Argentina may impair ADS holders' ability to receive dividends, distributions, or sale proceeds.

15-04-2026

Tradewinds Capital Management, LLC filed its 13F-HR on April 15, 2026, disclosing holdings as of March 31, 2026, across 719 positions with a total portfolio value of $503,547,089. Top holdings include Apple Inc. COM (16,422 shares valued at $4,167,655), Amazon.com Inc. COM (13,870 shares valued at $2,888,705), Exxon Mobil Corp. COM (13,545 shares valued at $2,298,064), Alphabet Inc. CAP STK CL C (6,911 shares valued at $1,982,555), and Berkshire Hathaway Inc. DEL CL B NEW (2,311 shares valued at $1,107,432). The portfolio features a diversified mix of equities, ETFs, and other securities held solely.

• ·Filer CIK: 0001616026
• ·SEC File Number: 028-16264
• ·Business address: 2211 Rimland Drive, Suite 401, Bellingham, WA 98226
• ·All holdings reported with sole voting and disposition power (SH SOLE)

15-04-2026

OGE Energy Corp. filed a supplement to its April 1, 2026 proxy statement for the May 14, 2026 Annual Meeting, announcing that Board member Luther C. Kissam, IV will not stand for re-election and will resign effective at the meeting due to accepting a new CEO position at another company. The Board size will reduce to eight directors, with the slate of other nominees unchanged and no impact on other agenda items. Previously submitted proxies remain valid except with respect to Mr. Kissam, and no disagreements exist with Company operations, policies, or practices.

• ·Mr. Kissam informed Company of resignation decision on April 13, 2026
• ·Mr. Kissam served more than five years on the Board and various committees
• ·Supplement dated April 14, 2026; filing date April 15, 2026

15-04-2026

Pantages Capital Acquisition Corporation filed an 8-K disclosing Amendment No. 1 to its Business Combination Agreement originally dated November 18, 2025, executed on April 14, 2026. The sole change amends and restates Section 8.1(h) to be intentionally omitted, with all other terms of the agreement remaining in full force and effect. The amendment involves parties including MacMines Austasia Pty Ltd (Company), Horizon Mining Limited (Pubco), and others, signed by key representatives.

• ·Original Business Combination Agreement dated November 18, 2025.
• ·Amendment filed as EX-2.1 under Items 1.01 and 9.01 of 8-K on April 15, 2026.

15-04-2026

Bayforest Capital Ltd, based in London, filed its 13F-HR on April 15, 2026, disclosing institutional holdings as of March 31, 2026, consisting of 879 positions held with sole voting authority. The total portfolio market value stands at $89305335, spanning diverse sectors including healthcare, technology, financials, and industrials, with individual positions ranging from small stakes like 9 shares in Becton Dickinson to larger ones like 24087 shares in DraftKings. No period-over-period changes are detailed in this filing.

• ·All 879 positions held with sole voting authority (SH SOLE).
• ·Portfolio includes small-cap and mid-cap names across 100+ companies, with market values per position ranging from $949 (Avantor Inc) to $334392 (ABM INDS INC).

15-04-2026

Bank of America reported 1Q26 net income of $8.6 billion, up 17% YoY from $7.4 billion, with revenue of $30.3 billion up 7% YoY and net interest income of $15.7 billion up 9% YoY. Average deposits rose 3% to $2.02 trillion and loans increased 9% to $1.19 trillion, while segments showed strength in Global Wealth revenue (+12%) and Equities (+30%), but Consumer Banking revenue grew only 5%, FICC revenue +2%, and noninterest expense rose 4%. Provision for credit losses held flat at $1.3 billion versus 4Q25 amid stable asset quality.

• ·CET1 ratio of 11.2%; well above regulatory minimum
• ·Efficiency ratio improved 170 bps YoY to 61%
• ·Return on average tangible common equity 16.0%
• ·Net charge-offs $1.4B, up from $1.3B in 4Q25 due to credit card seasonality
• ·GWIM AUM flows $20.4B vs $24.0B in 1Q25

15-04-2026

Aspire Biopharma Holdings, Inc. entered into a non-binding letter of intent (LOI) on April 15, 2026, to acquire 100% of the Driver Controls Systems (DCS) business unit of Firefish Topco, LLC for an enterprise value of $30.0 million on a cash-free, debt-free basis, payable in cash at closing subject to customary adjustments. The LOI includes $3.5 million break-up fees, a 30-day exclusivity period with no-shop provisions, and plans to engage Lakewood & Company, LLC for post-acquisition management services. Completion remains subject to definitive agreements and conditions, with no new equity raise anticipated.

• ·LOI is non-binding except for exclusivity, confidentiality, expenses, and break-up fees post-disclosure.
• ·Purchase not subject to working capital adjustment if operated in ordinary course.
• ·Lakewood & Company principals have more than 100 years of automotive industry experience.

15-04-2026

Arbutus Biopharma Corporation announced on April 15, 2026, that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to imdusiran for the treatment of chronic hepatitis B. This FDA program facilitates the development and expedites review of investigational therapies addressing serious conditions with unmet medical needs. The press release is attached as Exhibit 99.1.

• ·Date of earliest event reported: April 14, 2026
• ·Filing Date: April 15, 2026

15-04-2026

Prelude Therapeutics Incorporated (Nasdaq: PRLD) announced the appointment of Dr. Charles Morris, M.D. as Chief Medical Officer effective April 20, 2026, to lead the advancement of its two lead programs targeting myeloproliferative neoplasms and ER+ breast cancer into clinical development in 2026. Dr. Morris brings over 30 years of oncology drug development experience, including prior CMO roles at Lava Therapeutics, Celyad Oncology, Radius Health, ImmunoGen, and Allos Therapeutics, and contributions to approvals of ONSERDU, ELAHERE, and Faslodex. CEO Kris Vaddi highlighted Dr. Morris's expertise as instrumental for executing these programs with rigor.

• ·Dr. Morris holds a medical degree and Bachelor of Medical Science in Clinical Pharmacology and Therapeutics from Sheffield University Medical School and is a Member of the Royal College of Physicians of London.
• ·Investor contact: Robert A. Doody, Jr. at 484.639.7235 or rdoody@preludetx.com

15-04-2026

Barfresh Food Group Inc. (BRFH) filed an S-1 registration statement on April 15, 2026, to register up to 5,550,602 shares for resale by selling stockholders, including Conversion Shares, Interest Shares, and Warrant Shares, with potential gross proceeds of $7.5 million if warrants are exercised for working capital. The company highlights benefits from its October 3, 2025 acquisition of Arps Dairy, Inc., gaining in-house manufacturing (18% of supply in Q4 2025), a $2.4 million grant for a new 44,000 sq ft facility operational in late 2026, and $7,528,000 raised in March 2026 to retire $2,541,000 debt. However, it notes a history of operating losses, integration risks from the acquisition, and new exposure to dairy processing operational challenges.

• ·Principal executive offices at 12100 Wilshire Boulevard, 8th Floor, Los Angeles, California, 90025.
• ·Existing Facility at 220 N. Clinton Drive, Defiance, Ohio; New Facility at 136 Fox Run Drive, Defiance, Ohio.
• ·Common Stock trading on Nasdaq Capital Market under symbol BRFH since January 20, 2022.
• ·Company formed via reverse merger in 2012 into Delaware corporation established February 25, 2010.

15-04-2026

JP Wealth Management, Inc. filed a 13F-HR disclosing 15 equity positions totaling $147467866 as of March 31, 2026. Largest holdings include DFA U S Core Equity 2 (DFAC) valued at $31438245, Nasdaq 100 (QQQM) at $27930568, and SRH Total Return Fund (STEW) at $26602385. The portfolio features a mix of broad market ETFs, growth/value funds, gold ETF, and income funds, with all positions held solely.

• ·Other holdings: Russell 1000 Growth i-share (IWF) $2302560 (5400 shares); S&P 500 SPDR (SPY) $234773 (361 shares); Vguard Value index (VTV) $765180 (3900 shares); Russell 1000 Value i-share (IWD) $1114503 (5216 shares); Russell Midcap Value i-share (IWR) $570546 (5868 shares); ISHARES TR (IWO) $218726 (697 shares); DIMENSIONAL ETF TRUST (DFNM) $808579 (16870 shares).
• ·All positions held with sole voting authority (SOLE).
• ·Filing submitted April 15, 2026 for quarter ended March 31, 2026.

15-04-2026

LongView Wealth Management filed its Form 13F-HR on April 15, 2026, disclosing $398,059,583 in total equity holdings across 247 positions as of March 31, 2026. The portfolio features top holdings including iShares TR Morningstar Growth (14330145 value), Apple Inc. COM (13837758 value), and Fidelity Merrimack STR TR Total BD ETF (13786400 value), with heavy allocations to ETFs from iShares, Schwab Strategic Trust, Capital Group, and individual stocks like Home Depot and Nvidia. No changes from prior periods are indicated in the filing, and all positions are held with sole voting power.

• ·Filing covers period ending March 31, 2026.
• ·Business address: 5605 Glenridge Drive, Suite 300, Atlanta, GA 30342.
• ·Central Index Key: 0001990190.
• ·SEC File Number: 028-23492.

15-04-2026

Five Star Bancorp issued a press release on April 14, 2026, announcing the anticipated dates for its earnings release and webcast reporting financial results for the first quarter ended March 31, 2026. The press release is furnished as Exhibit 99.1 under Item 7.01 (Regulation FD Disclosure) and is not deemed filed. No financial metrics or performance details were disclosed in the filing.

• ·Filing date: April 15, 2026
• ·Date of earliest event reported: April 14, 2026
• ·Securities registered: Common Stock, no par value per share (FSBC) on The Nasdaq Stock Market LLC

15-04-2026

Employees Provident Fund Board filed a 13F-HR report disclosing 43 US equity positions totaling $2282681994 as of March 31, 2013, with no prior period data for comparison. Top holdings by market value include Apple Inc ($213431317), Exxon Mobil Corp ($181007561), and Microsoft Corp ($160135177). The report was filed on April 15, 2026, and signed by N Ahmad Ridzuan Bin Wan Idrus, Head of Investment Services Department.

• ·All positions held with sole voting authority.
• ·Report covers period ending 03-31-2013.
• ·Additional notable holdings: AT&T Inc (1210821 shares, $44425022), Coca Cola Co (1698294 shares, $68679009), Intel Corp (3300247 shares, $72110397).

15-04-2026

21 West Wealth Management LLC filed its 13F-HR report disclosing 63 investment positions with a total market value of $107,654,790 as of March 31, 2026. The portfolio consists primarily of ETFs (e.g., J.P. Morgan Municipal ETF at $7,667,266 and Vanguard S&P 500 ETF at $7,338,512) and individual stocks (e.g., NVIDIA at $2,193,603 and Apple at $1,480,865), all held with sole voting rights. No changes from other managers or prior periods are indicated in the filing.

• ·Filed on April 15, 2026 for period ending March 31, 2026
• ·All positions held as SOLE (sole voting authority) with no other managers reported
• ·Business address: 2522 Chambers Road, Suite 100, Tustin, CA 92780

15-04-2026

Wealth Intelligence, LLC disclosed total equity holdings of $207,953,897 across 58 positions in its 13F-HR filing as of March 31, 2026. The portfolio is concentrated with Lowe's Companies Inc. as the largest holding at $71,280,699 (301,679 shares), followed by First Trust Exchange-Traded FD Core Investment at $19,748,093 (942,180 shares) and Apple Inc. at $6,697,645 (26,390 shares). All positions are held solely on a discretionary basis with no other voting authority or shared discretion reported.

• ·Filing submitted on April 15, 2026, for period ending March 31, 2026
• ·Headquartered at 2900 Warm Springs Rd, Columbus, GA 31904
• ·58 holdings all reported as SH SOLE (sole discretionary voting authority)

15-04-2026

Paragon Capital Management Ltd disclosed its Q1 2026 13F-HR holdings totaling $475997787 across 199 positions as of March 31, 2026, with all positions held under sole voting power and no puts or calls reported. Largest holdings include Vanguard Specialized Funds Dividend Appreciation ETF ($64991529, 302201 shares), Invesco Exchange Traded Fund Trust S&P 500 Quality ETF ($54060283, 718982 shares), and iShares Trust MSCI Intl Quality Factor ETF ($28023269, 606170 shares). The portfolio features a diversified mix of ETFs and individual stocks across sectors including technology (e.g., DigitalOcean Holdings $26406687), financials, and energy.

• ·Filing date: April 15, 2026
• ·Report period end: March 31, 2026
• ·All holdings reported with sole voting power (SH SOLE); no shared voting power, puts, or calls
• ·Firm address: 999 18th Street, Suite 1401, Denver, CO 80202

15-04-2026

Birch Capital Management, LLC filed its 13F-HR on April 15, 2026, reporting 78 equity positions held as of March 31, 2026, with all under sole discretionary authority. Top holdings by market value include Apple Inc. at $16186541 (63779 shares), W.W. Grainger Inc. at $15601328 (14303 shares), and Microsoft Corp. at $11701096 (31610 shares). Other notable positions feature FedEx Corp. ($9824157, 27582 shares) and Amgen Inc. ($8752435, 24875 shares), spanning technology, industrials, healthcare, and ETFs.

• ·SEC file number: 028-19686
• ·CIK: 0001799859
• ·Business address: 5503 Bent Tree Drive, Dallas, TX 75248
• ·All reported shares under sole voting authority (SH SOLE); no shared or other authority

15-04-2026

Diligent Investors, LLC filed its quarterly 13F-HR on April 15, 2026, reporting holdings as of March 31, 2026, across 346 positions with a total market value of $403704647. The portfolio is diversified with top individual stock holdings in Apple Inc. ($16693256, 65776 shares), Berkshire Hathaway Inc. CL B ($5641622, 11773 shares), Chevron Corporation ($5364107, 25926 shares), Amazon.com Inc. ($4441942, 21328 shares), and Alphabet Inc. CAP STK CL A ($4034631, 14031 shares), alongside heavy allocations to First Trust and Innovator ETFs. All positions are held solely with investment discretion and no put/call options.

• ·All holdings reported with sole investment discretion (SH SOLE).
• ·No put or call options reported (0 0).
• ·Business address: 1447 Ford Street, #200, Redlands, CA 92374.
• ·SEC file number: 028-16635.
• ·Fiscal year end: 12/31.

15-04-2026

Oak Asset Management, LLC filed its 13F-HR disclosing holdings as of March 31, 2026, totaling $290437600000 across 108 positions, all held on a sole discretionary basis with no put or call options. Top holdings by market value include Apple Inc. ($32399103000, 127661 shares), Amgen Inc. ($20425514000, 58052 shares), NVIDIA Corporation ($16326979000, 93618 shares), and Chevron Corporation ($16291927000, 78743 shares). The portfolio reflects a diversified mix of large-cap stocks and ETFs with no period-over-period changes detailed in this filing.

• ·All positions reported as SH SOLE with 0 put options and 0 call options.
• ·Portfolio includes a mix of individual stocks (e.g., technology, healthcare, energy) and ETFs (e.g., iShares TR, Vanguard Index FDS).
• ·Conformed period of report: 2026-03-31; Filed as of: 2026-04-15.

15-04-2026

Buttonwood Financial Group, LLC filed Form 13F-HR on April 15, 2026, disclosing its equity holdings as of March 31, 2026, consisting of 30 positions primarily in ETFs with sole discretionary authority and no reported voting authority. Key holdings include iShares US Equity ETF valued at $30,734,363 (528,266 shares), Avantis Emerging Markets ETF at $20,071,514 (249,088 shares), and SPDR Series Trust ETF (CUSIP 78464A854) at $16,753,806 (218,889 shares), alongside diversified exposure to US large cap, AI innovation, defense tech, ESG, gold, municipals, and MBS. The portfolio also features a minor position in Sherwin-Williams Co stock ($576,990, 1,800 shares).

• ·Filer CIK: 0001847661, SEC file number: 028-22545
• ·All positions held solely with investment discretion (SH SOLE), voting authority sole/shared/none: 0/0/[shares]
• ·Business address: 3013 Main Street, Kansas City, MO 64108; Phone: 816-285-9000
• ·Period of report: March 31, 2026; Filed as of: April 15, 2026

15-04-2026

WEBSTERROGERS FINANCIAL ADVISORS, LLC filed Form 13F-HR on April 15, 2026, reporting institutional holdings as of March 31, 2026. The portfolio totals $349,515,048 across 95 positions, all held on a sole discretionary basis, with major allocations to ETFs such as Vanguard Growth ETF ($28,614,188), Vanguard Scottsdale Fds Short Term Treas ($13,658,929), and Dimensional ETF Trust US Core Equity 2 ($9,173,254), alongside stocks like Apple Inc. ($1,369,333) and Microsoft Corp. ($844,360). No prior period data or performance changes are disclosed in the filing.

• ·Report period end date: March 31, 2026
• ·All 95 positions held with sole voting authority (SH SOLE) and no shared discretion
• ·Firm address: 1411 Second Loop Road, Florence, SC 29505-2801

15-04-2026

John Marshall Bancorp, Inc. announced on April 15, 2026, the initiation of equity research coverage on its common stock by Raymond James & Associates, Inc. The press release detailing this event is attached as Exhibit 99.1. This development is filed under Items 8.01 and 9.01 of Form 8-K.

15-04-2026

PEREGRINE INVESTMENT MANAGEMENT INC filed a 13F-HR report on April 15, 2026, disclosing 20 equity holdings as of March 31, 2026, with a total portfolio market value of $127197748. All positions are held with sole voting and sole investment discretion power (0 shared). Holdings are concentrated in technology and semiconductor names, including Amazon.com Inc. (42740 shares valued at $8901460), Xometry Inc. (215100 shares at $8784684), and Netflix Inc. (90000 shares at $8653500).

• ·Filing CIK: 0002053303
• ·SEC File Number: 028-24690
• ·Business address: 22 Adelaide Street West, Bay Adelaide Centre, Suite 2040, Toronto A6 M5H4E3
• ·Phone: 4169452765
• ·All holdings report sole voting power (SH SOLE) and zero shared voting/disposition power

15-04-2026

Huntington Bancshares Incorporated completed its acquisition of Cadence Bank on February 1, 2026, pursuant to a Merger Agreement dated October 26, 2025. This Form 8-K/A amends the original filing to include Cadence's audited consolidated financial statements as of December 31, 2025 and 2024, and for the fiscal years ended December 31, 2025, 2024, and 2023 (Exhibit 99.1), as well as unaudited pro forma condensed combined financial statements for Huntington as of December 31, 2025 (balance sheet) and for the year then ended (income statement, as if transaction occurred January 1, 2025) (Exhibit 99.2). The pro forma information is for informational purposes only and does not reflect actual or projected results.

• ·Merger Agreement dated October 26, 2025
• ·Original Form 8-K filed February 2, 2026
• ·Pro forma balance sheet as if transaction on December 31, 2025
• ·Pro forma income statement as if transaction on January 1, 2025
• ·Consent of Forvis Mazars, LLP (Exhibit 23.1)

15-04-2026

On April 14, 2026, Launchpad Cadenza Acquisition Corp I appointed Sheldon Sussman, age 70, as a new member of the Board of Directors effective immediately, and as chair of the Audit Committee, replacing Jonathan Bier who remains a member. Sussman brings extensive experience in global financial markets, including roles at Napier Park Global Capital, Cohen Circle, and building a $25 billion asset management platform at Rabobank International. No family relationships, material transactions, or compensatory arrangements beyond standard agreements were disclosed.

• ·Appointment effective April 14, 2026; filing date April 15, 2026.
• ·Sussman signed joinder to letter agreement dated December 17, 2025 (waiver of redemption rights, vote in favor of initial business combination).
• ·Sussman signed joinder to registration rights agreement dated December 17, 2025.
• ·Standard director indemnity agreement (form filed as Exhibit 10.6 to S-1 on November 10, 2025).

15-04-2026

Eton Pharmaceuticals, Inc. entered into the Sixth Amendment to its Credit Agreement, originally dated November 13, 2019, with SWK Funding LLC as agent and sole lender, effective April 9, 2026. The amendment updates Annex I to confirm SWK Funding LLC's $40,000,000 term loan commitment at 100% pro rata share. Effectiveness is conditioned on the consummation of mergers under the October 9, 2025 Agreement and Plan of Merger involving Runway Growth Finance Corp. and SWK Holdings Corporation, with no changes to financial performance metrics disclosed.

• ·Amendment filed as 8-K on April 15, 2026, covering Items 1.01, 2.03, and 9.01
• ·Conditions precedent include payment of Agent’s and Runway’s outside counsel fees, true and correct representations/warranties, and no Default or Event of Default
• ·No waiver of any past, present, or future non-compliance under the Credit Agreement